Back to Home

Bicara Therapeutics

BCAX $23.90 USD~$300M MCAP

Bicara Therapeutics is a clinical-stage oncology biotech developing bifunctional antibody therapies for solid tumors, including head and neck squamous cell carcinoma.

Company Info

Sector:Oncology
Headquarters:Boston, MA, USA
Founded:2020

Recent News

Leadership Team

Careers & Job Openings

See all open roles

Various
Various
Apply Now